Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Torp-Pedersen

Showing results (51-60 of 167) with videos related to

Pageof 17
Sort By:
Annals of the New York Academy of Sciences|April 28, 1978
Calcium and neurosecretionN A Thorn, J T Russell, C Torp-Pedersen, et al.
The American Journal of Cardiology|November 14, 1997
Do diabetes mellitus and systemic hypertension predispose to left ventricular free wall rupture in acute myocardial infarction?T Melchior, P Hildebrant, L Køber, et al.
Journal of the American College of Cardiology|July 10, 1999
Effect of the angiotensin-converting enzyme inhibitor trandolapril on mortality and morbidity in diabetic patients with left ventricular dysfunction after acute myocardial infarction. Trace Study GroupI Gustafsson, C Torp-Pedersen, L Køber, et al.
European Heart Journal|December 1, 1994
An echocardiographic method for selecting high risk patients shortly after acute myocardial infarction, for inclusion in multi-centre studies (as used in the TRACE study). TRAndolapril Cardiac EvaluationL Køber, C Torp-Pedersen, J Carlsen, et al.
Clinical Pharmacology and Therapeutics|May 27, 2017
Response to "No Obvious Extra Cardiovascular Risk Associated With Low-Dose NSAIDs," "Do NSAIDs Actually Protect Against Myocardial Infarction and Death?," and "Are Myocardial Infarctions and Death in Healthy Individuals Associated With the Use of Cyclooxygenase Inhibitors?"E L Fosbøl, G H Gislason, L Køber, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|May 1, 1996
Clinical characteristics, left and right ventricular ejection fraction, and long-term prognosis in patients with non-insulin-dependent diabetes surviving an acute myocardial infarctionT Melchior, N Gadsbøll, P Hildebrandt, et al.
European Heart Journal|March 1, 1990
Feasibility of intracardiac injection of drugs during cardiac arrestH F Jespersen, J Granborg, U Hansen, et al.
Hoppe-Seyler'S Zeitschrift Fur Physiologische Chemie|November 1, 1980
Isolation and characterization of secretory vesicles from bovine neurohypophysesM Gratzl, C Torp-Pedersen, D Dartt, et al.
The American Journal of Cardiology|June 19, 1998
Changes in absolute and relative importance in the prognostic value of left ventricular systolic function and congestive heart failure after acute myocardial infarction. TRACE Study Group. Trandolapril Cardiac EvaluationL Køber, C Torp-Pedersen, S Jørgensen, et al.
European Heart Journal|February 20, 2003
Cardiogenic shock complicating acute myocardial infarction; prognostic impact of early and late shock developmentM G Lindholm, L Køber, S Boesgaard, et al.
Pageof 17

Showing results (51-60 of 167) with videos related to

Sort By:
Pageof 17
Annals of the New York Academy of Sciences|April 28, 1978
Calcium and neurosecretionN A Thorn, J T Russell, C Torp-Pedersen, et al.
The American Journal of Cardiology|November 14, 1997
Do diabetes mellitus and systemic hypertension predispose to left ventricular free wall rupture in acute myocardial infarction?T Melchior, P Hildebrant, L Køber, et al.
Journal of the American College of Cardiology|July 10, 1999
Effect of the angiotensin-converting enzyme inhibitor trandolapril on mortality and morbidity in diabetic patients with left ventricular dysfunction after acute myocardial infarction. Trace Study GroupI Gustafsson, C Torp-Pedersen, L Køber, et al.
European Heart Journal|December 1, 1994
An echocardiographic method for selecting high risk patients shortly after acute myocardial infarction, for inclusion in multi-centre studies (as used in the TRACE study). TRAndolapril Cardiac EvaluationL Køber, C Torp-Pedersen, J Carlsen, et al.
Clinical Pharmacology and Therapeutics|May 27, 2017
Response to "No Obvious Extra Cardiovascular Risk Associated With Low-Dose NSAIDs," "Do NSAIDs Actually Protect Against Myocardial Infarction and Death?," and "Are Myocardial Infarctions and Death in Healthy Individuals Associated With the Use of Cyclooxygenase Inhibitors?"E L Fosbøl, G H Gislason, L Køber, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|May 1, 1996
Clinical characteristics, left and right ventricular ejection fraction, and long-term prognosis in patients with non-insulin-dependent diabetes surviving an acute myocardial infarctionT Melchior, N Gadsbøll, P Hildebrandt, et al.
European Heart Journal|March 1, 1990
Feasibility of intracardiac injection of drugs during cardiac arrestH F Jespersen, J Granborg, U Hansen, et al.
Hoppe-Seyler'S Zeitschrift Fur Physiologische Chemie|November 1, 1980
Isolation and characterization of secretory vesicles from bovine neurohypophysesM Gratzl, C Torp-Pedersen, D Dartt, et al.
The American Journal of Cardiology|June 19, 1998
Changes in absolute and relative importance in the prognostic value of left ventricular systolic function and congestive heart failure after acute myocardial infarction. TRACE Study Group. Trandolapril Cardiac EvaluationL Køber, C Torp-Pedersen, S Jørgensen, et al.
European Heart Journal|February 20, 2003
Cardiogenic shock complicating acute myocardial infarction; prognostic impact of early and late shock developmentM G Lindholm, L Køber, S Boesgaard, et al.
Pageof 17